Lower Risk for Tertiary Hyperparathyroidism With PTx
In a study of patients on dialysis, those treated with parathyroidectomy instead of cinacalcet had a lower risk of developing tertiary hyperparathyroidism.
Secondary Hyperparathyroidism
Nutritional Vitamin D Unreliable as SHPT Treatment in NDD-CKD
Nutritional vitamin D supplements are frequently used to treat secondary hyperparathyroidism, especially in early chronic kidney disease, but they do not substantially lower parathyroid hormone levels, according to a meta-analysis.
Upacicalcet May Improve Secondary Hyperparathyroidism
The novel intravenous calcimimetic might cause fewer gastrointestinal symptoms, new research suggests.
Risk of Nonspinal Fracture Increased in Moderate to Severe CKD
Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.
Post-Kidney Transplant Complication Rate Lower With PTx
Parathyroidectomy prior to kidney transplantation is associated with a lower risk for severe postoperative complications compared with calcimimetic treatment, according to investigators.
Calcimimetic Resistance in SHPT Does Not Worsen Parathyroidectomy Outcomes
Patients undergoing parathyroidectomy for SHPT that is refractory to calcimimetics frequently show significant enlargement of the parathyroid glands as well as histopathologic alterations, new findings suggest.
Possibly Safer Way to Correct Calcimimetic-Induced Hypocalcemia Reported
In a study, investigators tested etelcalcetide combination therapies in patients on maintenance hemodialysis who have secondary hyperparathyroidism.
Cinacalcet, Paricalcitol Similarly Efficacious in Controlling PTH
The selective vitamin D analog and calcimimetic were both beneficial in decreasing parathyroid hormone levels, according to the authors of a new meta-analysis.
Incorporating Calcimimetics Into Dialysis Payment Bundle Poses Challenges
According to a study, 1 in 5 dialysis facilities might face financial losses if calcimimetics are included in the payment bundle, and providers may feel pressured to reduce calcimimetic use.
Cinacalcet Found Not to Reduce Death Risk
The latest meta-analysis, however, confirms that the calcimimetic improves biochemical parameters, such as parathyroid hormone levels.
-
Loading...
-
Loading...
Next post in Secondary Hyperparathyroidism
